malignant tumor
Conditions
Interventions
None listed
Sponsors
International University of Health and Welfare Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients undergoing first-line chemotherapy or first-line. recurrent chemotherapy for solid cancer Patients with Eastern Cooperative Oncology Group Performance Status 4. Patients for whom free and voluntary consent to participate in research can be obtained in writing from the individual. Patients aged 18 years or older at the time of obtaining consent.
Exclusion criteria
Exclusion criteria: Patients with CTCAE grade 2 or higher side effects prior to chemotherapy administration. Patients who are unable to properly complete the elderly functional assessment chart(dementia, etc.) If a family member who lives with the respondent can answer the question, the respondent is not excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To investigate the functional assessment of the elderly and the incidence of side effects during the first 6 months of treatment. Elderly functional assessment will evaluate VES13, cognitive function, such as G8 | — |
Secondary
| Measure | Time frame |
|---|---|
| Type of side effect, reason for dose reduction, relative dose intensity | — |
Countries
Japan
Contacts
Public ContactManami Kazaoka
International University of Health and Welfare Hospital Department of Pharmacy
Outcome results
None listed